Kestra Medical Techs - Public Comps and Valuation Multiples

Kestra Medical Techs Overview

About Kestra Medical Techs

Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.

Founded

2021

HQ

Employees

n/a

Website

kestramedical.com

Sectors

Medical Supplies

Financials

LTM Revenue $70.2M

LTM EBITDA -$81.0M

EV

$964M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Kestra Medical Techs Financials

As of August 2025, Kestra Medical Techs reported last 12-month revenue of $70.2M and EBITDA of -$81.0M.

In the same period, Kestra Medical Techs generated $30.5M in LTM gross profit and -$114M in net income.

See Kestra Medical Techs valuation multiples based on analyst estimates

Kestra Medical Techs P&L

In the most recent fiscal year, Kestra Medical Techs reported revenue of $59.8M and EBITDA of -$98.0M.

Kestra Medical Techs expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Kestra Medical Techs valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$70.2M	XXX	$59.8M	XXX	XXX	XXX
Gross Profit	$30.5M	XXX	$24.2M	XXX	XXX	XXX
Gross Margin	43%	XXX	40%	XXX	XXX	XXX
EBITDA	-$81.0M	XXX	-$98.0M	XXX	XXX	XXX
EBITDA Margin	-115%	XXX	-164%	XXX	XXX	XXX
EBIT	-$111M	XXX	-$106M	XXX	XXX	XXX
EBIT Margin	-158%	XXX	-178%	XXX	XXX	XXX
Net Profit	-$114M	XXX	-$114M	XXX	XXX	XXX
Net Margin	-162%	XXX	-190%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Kestra Medical Techs including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $70.2M. EBITDA for the last twelve months was -$81.0M. In the most recent fiscal year, Kestra Medical Techs achieved $59.8M in revenue and -$98.0M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$70.2M	Analyst estimates available to subscribers	$59.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$30.5M	Analyst estimates available to subscribers	$24.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	43.4% gross margin	Analyst estimates available to subscribers	40.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$81.0M	Analyst estimates available to subscribers	-$98.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-115.4% EBITDA margin	Analyst estimates available to subscribers	-163.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$111M	Analyst estimates available to subscribers	-$106M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-158.0% EBIT margin	Analyst estimates available to subscribers	-177.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$114M	Analyst estimates available to subscribers	-$114M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-162.4% net profit margin	Analyst estimates available to subscribers	-190.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Kestra Medical Techs

This financial data table provides comprehensive performance metrics for Kestra Medical Techs, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Kestra Medical Techs generated $70.2M in revenue over the last twelve months.
The company achieved -$81.0M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $30.5M.
Net income over the last twelve months reached -$114M.

Fiscal Year Performance

In the most recent fiscal year, Kestra Medical Techs reported $59.8M in total revenue.
Fiscal year EBITDA was -$98.0M.
The company maintained a gross profit margin of 40.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was -163.8%.
Net profit margin reached -190.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Kestra Medical Techs. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Kestra Medical Techs Stock Performance

Kestra Medical Techs has current market cap of $1.1B, and EV of $964M.

Market Cap Evolution

Kestra Medical Techs Stock Data

As of September 12, 2025, Kestra Medical Techs's stock price is $22.

See Kestra Medical Techs trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$964M	$1.1B	XXX	XXX	XXX	XXX	$-4.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Kestra Medical Techs Valuation Multiples

Kestra Medical Techs's trades at 19.6x EV/Revenue multiple, and -10.6x EV/EBITDA.

See valuation multiples for Kestra Medical Techs and 15K+ public comps

Kestra Medical Techs Financial Valuation Multiples

As of September 12, 2025, Kestra Medical Techs has market cap of $1.1B and EV of $964M.

Equity research analysts estimate Kestra Medical Techs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Kestra Medical Techs has a P/E ratio of -9.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.1B	XXX	$1.1B	XXX	XXX	XXX
EV (current)	$964M	XXX	$964M	XXX	XXX	XXX
EV/Revenue	13.7x	XXX	19.6x	XXX	XXX	XXX
EV/EBITDA	-11.9x	XXX	-10.6x	XXX	XXX	XXX
EV/EBIT	-8.7x	XXX	-9.7x	XXX	XXX	XXX
EV/Gross Profit	31.6x	XXX	n/a	XXX	XXX	XXX
P/E	-9.8x	XXX	-10.5x	XXX	XXX	XXX
EV/FCF	-9.9x	XXX	-10.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kestra Medical Techs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Kestra Medical Techs Margins & Growth Rates

Kestra Medical Techs's last 12 month revenue growth is 47%

Kestra Medical Techs's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Kestra Medical Techs's rule of 40 is -137% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kestra Medical Techs's rule of X is 3% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Kestra Medical Techs and other 15K+ public comps

Kestra Medical Techs Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	47%	XXX	54%	XXX	XXX	XXX
EBITDA Margin	-115%	XXX	-185%	XXX	XXX	XXX
EBITDA Growth	-7%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-137%	XXX	-137%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	3%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	26%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	218%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial